Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:505607.
doi: 10.4061/2011/505607. Epub 2011 May 18.

What Are the bona fide GSK3 Substrates?

Affiliations

What Are the bona fide GSK3 Substrates?

Calum Sutherland. Int J Alzheimers Dis. 2011.

Abstract

Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo. Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells. In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different signaling pathways regulate GSK3 activity by different mechanisms, and this could permit differential regulation of GSK3 substrate phosphorylation.
Figure 2
Figure 2
Potential physiological and pathological effects of phosphorylation of proposed GSK3 substrates.

References

    1. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. European Journal of Biochemistry. 1980;107(2):519–527. - PubMed
    1. Ishiguro K, Shiratsuchi A, Sato S, et al. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Letters. 1993;325(3):167–172. - PubMed
    1. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal. 2001;359(1):1–16. - PMC - PubMed
    1. Jope RS, Johnson GVW. The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences. 2004;29(2):95–102. - PubMed
    1. Bhat RV, Budd Haeberlein SL, Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. Journal of Neurochemistry. 2004;89(6):1313–1317. - PubMed

LinkOut - more resources